Boston Scientific Acquires Xlumena

April 1, 2015

Boston Scientific agreed to acquire Mountain View–based medical device company Xlumena, gaining the AXIOS and HOT AXIOS stent and delivery systems. The deal includes $62.5 million upfront, $12.5 million contingent on FDA clearance of HOT AXIOS and additional sales-based milestones, and is intended to expand Boston Scientific's endoscopy and EUS therapeutic capabilities and accelerate global commercialization of the AXIOS platform.

Buyers
Boston Scientific Corporation
Targets
Xlumena, Inc.
Industry
Medical Devices
Location
California, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.